Pharmaceutical
Upcoming Earnings
Biotechnology
Alexion Pharmaceuticals
$123.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$123.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.10 (0.08%) Today
+$1.08 (0.88%) As of 7:54 PM EDT after-hours
Why Robinhood?
You can buy or sell ALXN and other stocks, options, ETFs, and crypto commission-free!
About ALXN
Alexion Pharmaceuticals, Inc. Common Stock, also called Alexion Pharmaceuticals, is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Read More Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.
Employees
2,656
Headquarters
Boston, Massachusetts
Founded
1992
Market Cap
27.42B
Price-Earnings Ratio
67.06
Dividend Yield
0.00
Average Volume
1.46M
High Today
$123.07
Low Today
$121.52
Open Price
$122.42
Volume
1.54M
52 Week High
$141.86
52 Week Low
$92.56
Collections
Pharmaceutical
Upcoming Earnings
Biotechnology
Biopharmaceutical
Health
Therapy
Technology
US
ALXN News
Price Paid on Robinhood
1% Higher
Right Now
52 Week Low
$92.56
Average Price Paid
$122.77
52 Week High
$141.86
Analyst Ratings
80%
of 20 ratings
Buy
80%
Hold
20%
Sell
0%
ALXN Earnings
$1.28
$1.65
$2.02
$2.39
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$2.33 per share
Actual
Available Jul 24, Pre-Market